Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Oct 23, 2019

SELL
$6.16 - $9.6 $96,712 - $150,720
-15,700 Closed
0 $0
Q4 2018

Feb 05, 2019

BUY
$14.59 - $23.84 $4,377 - $7,152
300 Added 1.95%
15,700 $242,000
Q3 2018

Nov 08, 2018

SELL
$21.06 - $25.65 $64,232 - $78,232
-3,050 Reduced 16.53%
15,400 $332,000
Q2 2018

Aug 10, 2018

BUY
$16.77 - $24.71 $10,062 - $14,826
600 Added 3.36%
18,450 $449,000
Q1 2018

May 15, 2018

BUY
$16.68 - $22.07 $32,509 - $43,014
1,949 Added 12.26%
17,850 $305,000
Q4 2017

Feb 12, 2018

BUY
$11.23 - $19.1 $16,845 - $28,650
1,500 Added 10.42%
15,901 $301,000
Q3 2017

Nov 13, 2017

BUY
$15.41 - $32.17 $67,804 - $141,548
4,400 Added 44.0%
14,401 $253,000
Q2 2017

Aug 14, 2017

BUY
N/A
10,001
10,001 $332,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $18.2B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Lafayette Investments, Inc. Portfolio

Follow Lafayette Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lafayette Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Lafayette Investments, Inc. with notifications on news.